Integra Lifesciences Holdings Corp IART

NAS: IART | ISIN: US4579852082   23/04/2024
29,38 USD (+1,38%)
(+1,38%)   23/04/2024
Grafiek Integra Lifesciences Holdings Corp Grafiek Integra Lifesciences Holdings Corp
donderdag 25 april 2024, 13:00
Kwartaalcijfers (1ste kwartaal)

Integra Lifesciences Holdings Corp in het nieuws

13 november 2023 · Integra Final Deadline Alert · Persbericht

13 november 2023 · SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Integra Investors of a Lead Plaintiff Deadline of November 13, 2023 · Persbericht

11 november 2023 · SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART · Persbericht

9 november 2023 · SHAREHOLDER ALERT: Levi & Korsinsky Notifies Integra LifeSciences Holdings Corporation(IART) Investors of a Class Action Lawsuit and Upcoming Deadline · Persbericht

8 november 2023 · INTEGRA SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options · Persbericht

7 november 2023 · SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Integra LifeSciences Holdings Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 13, 2023 - (NASDAQ: IART) · Persbericht

7 november 2023 · IART Investors Have Opportunity to Lead Integra LifeSciences Holdings Corporation Securities Fraud Lawsuit · Persbericht

7 november 2023 · ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART · Persbericht

6 november 2023 · SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Integra Investors of a Lead Plaintiff Deadline of November 13, 2023 · Persbericht

4 november 2023 · INTEGRA LIFESCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART · Persbericht

Profiel Integra Lifesciences Holdings Corp

Gezondheidstechnologie
Medische Specialiteiten
Productie
Productie van analytische laboratoriuminstrumenten

Website: www.integralife.com

Hoofdzetel: Princeton, New Jersey vlag Verenigde Staten

CEO: Peter Arduini

Werknemers: 3.287

Aandelen Integra Lifesciences Holdings Corp

Beurswaarde: 2,28 miljard USD

Effecten: 78,60 miljoen

Winst per aandeel (12 maand):  PLUS

Koers-winstverhouding:  PLUS

Beta: 1,43

Mijn selecties